Company Filing History:
Years Active: 2015-2023
Title: Marlon Rebelatto: Innovator in Antibody Therapeutics
Introduction
Marlon Rebelatto is a distinguished inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of antibody therapeutics, holding a total of 7 patents. His work focuses on innovative methods for treating tumors and diseases associated with specific receptor functions.
Latest Patents
Among his latest patents, Rebelatto has developed "Anti-B7-H1 antibodies for treating tumors." This patent outlines methods for treating B7-H1-expressing tumors by administering an effective amount of MEDI4736 or an antigen-binding fragment thereof. Another notable patent is "Binding molecules specific for HER3 and uses thereof," which describes antibodies and antigen-binding fragments that bind to the extracellular domain of the HER3 receptor. This invention aims to inhibit various HER3 receptor-related functions through both ligand-dependent and ligand-independent mechanisms. Additionally, it includes compositions with increased half-life and methods for diagnosing and treating diseases linked to HER3-mediated signal transduction.
Career Highlights
Marlon Rebelatto has worked with prominent companies in the biotechnology sector, including MedImmune Limited. His experience in these organizations has allowed him to advance his research and contribute to the development of groundbreaking therapeutic solutions.
Collaborations
Throughout his career, Rebelatto has collaborated with notable professionals in the field, including Partha S Chowdhury and David Tice. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Marlon Rebelatto is a key figure in the development of antibody therapeutics, with a focus on innovative treatments for tumors and diseases. His contributions through patents and collaborations highlight his commitment to advancing medical science.